Allakos Inc.
DelistedCIK 1564824fmd_0YXFM3WY2KB981JP9HAA2XVPEWManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2016 to Mar 31, 2025, 34 periods
Latest annual · FY2024
Millions- Operating income
- (122)
- Net income
- (0)
- Free cash flow
- (94)
Latest quarter · Q1 FY2025
Millions- Operating income
- (27)
- Net income
- (26)
- Free cash flow
- (28)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2019 to FY2024
- n/m
Allakos Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2024 | FY2023 | Change | Source |
|---|---|---|---|---|
| Operating income | -$122.2 million | -$196.1 million | 10-K 2025-03-12 · proof | |
| Net income | -$115,818 | -$185,701 | 10-K/A 2025-04-17 · proof | |
| Cash from operating activities | -$93.6 million | -$116.5 million | 10-K 2025-03-12 · proof | |
| Free cash flow | -$93.7 million | -$117.1 million | 10-K 2025-03-12 · proof | |
| Total assets | $96.6 million | $243.6 million | -60.3% | 10-K 2025-03-12 · proof |
| Total liabilities | $17.8 million | $74.8 million | -76.2% | 10-K 2025-03-12 · proof |
| Cash and cash equivalents | $17.8 million | $66.4 million | -73.3% | 10-K 2025-03-12 · proof |
- What was Allakos Inc.'s operating income in fiscal 2024?
- Allakos Inc. reported operating income of -$122.2 million for fiscal 2024 (the year ended Dec 31, 2024), against -$196.1 million the year before. Source: the 10-K filed with the SEC on Mar 12, 2025. SEC
- What was Allakos Inc.'s net income in fiscal 2024?
- Allakos Inc. reported net income of -$115,818 for fiscal 2024 (the year ended Dec 31, 2024), against -$185,701 the year before. Source: the 10-K/A filed with the SEC on Apr 17, 2025 (restated). SEC
- What was Allakos Inc.'s cash from operating activities in fiscal 2024?
- Allakos Inc. reported cash from operating activities of -$93.6 million for fiscal 2024 (the year ended Dec 31, 2024), against -$116.5 million the year before. Source: the 10-K filed with the SEC on Mar 12, 2025. SEC
- What was Allakos Inc.'s free cash flow in fiscal 2024?
- Allakos Inc. reported free cash flow of -$93.7 million for fiscal 2024 (the year ended Dec 31, 2024), against -$117.1 million the year before. Source: the 10-K filed with the SEC on Mar 12, 2025. SEC
- What are Allakos Inc.'s total assets?
- As of Dec 31, 2024, Allakos Inc. reported total assets of $96.6 million, against $243.6 million a year earlier (-60.3%). Source: the 10-K filed with the SEC on Mar 12, 2025. SEC
- What are Allakos Inc.'s total liabilities?
- As of Dec 31, 2024, Allakos Inc. reported total liabilities of $17.8 million, against $74.8 million a year earlier (-76.2%). Source: the 10-K filed with the SEC on Mar 12, 2025. SEC
- What are Allakos Inc.'s cash and cash equivalents?
- As of Dec 31, 2024, Allakos Inc. reported cash and cash equivalents of $17.8 million, against $66.4 million a year earlier (-73.3%). Source: the 10-K filed with the SEC on Mar 12, 2025. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1564824&period_type=annual&limit=5"Information only, not investment advice.